Pharmafile Logo
Pharmafocus logo
Advanced Search

Vaccine

Showing 15 posts of 293 posts found.

World’s first Alzheimer’s vaccine trial begins

January 10, 2014
Research and Development, Sales and Marketing AC Immune, ACI-35, Alzheimer's, Vaccine

AC Immune, a privately-held biotech based in Switzerland, has launched the world’s first trial of a vaccine against a protein …

News
HPV vaccine image

GAVI begins roll-out of cheap HPV vaccine

October 17, 2013
Sales and Marketing GAVI, HPV, Vaccine

For the first time women in parts of the world with the highest cervical cancer death rate will be able …

News
Malaria image

GSK sets malaria vaccine roll-out date to 2015

October 8, 2013
Research and Development, Sales and Marketing GSK, Vaccine, malaria, rts, s

GlaxoSmithKline says it is just two years away from marketing the world’s first malaria vaccine RTS,S. This follows results from …

News
Vaccine image

Calls to end UK anti-vaccine magazine

October 2, 2013
Medical Communications, Sales and Marketing Cancer, Vaccine, sense about science

British retailers like Tesco and WH Smiths are being urged to drop an anti-vaccine magazine as it could be dangerous …

News
Malaria image

Sanaria’s malaria vaccine shows promise

August 9, 2013
Research and Development, Sales and Marketing PfSPZ, Vaccine, malaria, sanaria

Researchers in the US have announced promising results from a Phase I clinical trial of biotech firm Sanaria’s new malaria …

News

Bayer signs cancer vaccine research deal

August 6, 2013
Research and Development, Sales and Marketing Bayer, Vaccine, compugen

Bayer has entered into a new collaboration with Compugen to develop cancer vaccines aimed at helping the body fight off …

News

UK rejects meningitis B vaccine Bexsero

July 25, 2013
Sales and Marketing Bexsero, Novartis, Vaccine, meningitis b

The UK government’s department for vaccinations has stunned observers by failing to back the world’s only vaccine for meningitis B. …

News
Vaccine image

Diabetes vaccine trial posts positive results

June 28, 2013
Research and Development, Sales and Marketing TOL-3021, Vaccine, diabetes

A groundbreaking new study suggests that the body’s immune system can be taught to reverse the effects of type 1 …

News
GSK image

FDA delays GSK flu vaccine

March 27, 2013
Research and Development, Sales and Marketing FDA, GSK, Vaccine

The FDA has cooled on GlaxoSmithKline’s latest vaccine for a bird flu pandemic, Q-Pan H5N1, despite a vote of confidence …

News
cell vaccine image

Vaccine manufacturing emerges as outsourcing market

January 28, 2013
Manufacturing and Production R&D, Vaccine, outsourcing

Healthy growth in the market for vaccines – coupled with high production costs – look set to create a vaccine …

News
Sanofi image

Setback for Sanofi dengue vaccine

September 13, 2012
Research and Development, Sales and Marketing Dengue fever, Sanofi, Sanofi Pasteur, Vaccine

Sanofi Pasteur’s vaccine for dengue fever has failed to show protection against a key serotype of the potentially fatal illness. …

News
immatics image

immatics’ vaccine increases survival in kidney cancer

July 30, 2012
Research and Development, Sales and Marketing IMA901, Vaccine, Yervoy, immatics, phase III

immatics’ investigational cancer vaccine has increased survival rates in patients with renal cell carcinoma. In a late-stage trial, the German …

News

GSK faces fine over Argentina clinical trial

January 6, 2012
Research and Development, Sales and Marketing Argentina, GSK, Vaccine, deaths, emerging markets

A court in Argentina says GSK should be fined for irregularities in recruitment during a trial in which children died. …

News

Novartis submits meningococcal vaccine Bexsero for European approval

December 23, 2010
Sales and Marketing Bexsero, MenB, Novartis, Vaccine, bacterial meningitis, bloodstream infection sepsis, meningococcal disease, meningococcal vaccine

Novartis has submitted its meningococcal vaccine Bexsero to European regulators for marketing approval. If approved the drug will be the …

News

GSK shingles vaccine enters late stage trials

August 23, 2010
Research and Development, Sales and Marketing GSK, Vaccine, shingles

GlaxoSmithKline has started enrollment for phase III trials for its herpes zoster vaccine for the prevention of shingles. The trials …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025